↓ Skip to main content

Dove Medical Press

Article Metrics

Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, March 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
63 Mendeley
Title
Efficacy, safety, and impact on hospitalizations of paliperidone palmitate in recent-onset schizophrenia
Published in
Neuropsychiatric Disease and Treatment, March 2015
DOI 10.2147/ndt.s77778
Pubmed ID
Authors

Fan Zhang, Tianmei Si, Chiun-Fang Chiou, Anthony Harris, Chang Yoon Kim, Padmashree Jahagirdar, Steve Ascher

Abstract

To evaluate the efficacy, safety, and impact on hospitalizations of long-acting injectable paliperidone palmitate (PP) treatment, in patients with recent-onset schizophrenia who had not responded satisfactorily to oral antipsychotics.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 62 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 16%
Student > Master 9 14%
Student > Bachelor 9 14%
Student > Postgraduate 6 10%
Student > Ph. D. Student 5 8%
Other 14 22%
Unknown 10 16%
Readers by discipline Count As %
Medicine and Dentistry 17 27%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Neuroscience 5 8%
Psychology 5 8%
Nursing and Health Professions 4 6%
Other 9 14%
Unknown 17 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 March 2015.
All research outputs
#11,132,949
of 12,517,383 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,945
of 2,120 outputs
Outputs of similar age
#184,396
of 221,423 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#8
of 8 outputs
Altmetric has tracked 12,517,383 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,120 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 221,423 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one.